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London, Ontario, CanadaThe role of and indications for interventions for renal artery
stenosis (RAS) have long been a hot topic of debate. Despite
numerous reports and studies over the years, there remain
many unanswered questions. Among them are: Who should
be intervened upon? What should be the objectives of
intervention? What is the optimal mode of intervention?
More recently, several randomized studies have attempted
to answer some of these basic questions, but unfortunately
have left many unanswered questions. In the following
debate the authors consider the existing literature and
attempt to convince us that the majority, or the minority of
patients with renal artery stenoses should be intervened
upon.
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Introduction
The debate position given to this author may on first glance
appear to be untenable. I hope to convince you that the
opposite stance of not treating patients with renal artery
stenosis (RAS) neglects the opportunity to help some
patients with correctable hypertension and renal dysfunc-
tion. Frankly, either debate position is difficult to defend
given our dearth of solid information in the arena of reno-
vascular disease. As a medical community, we have scant
evidence on the natural history of renal artery stenosis and
the kidneys these arteries are supplying. Furthermore, the
available data is far from convincing especially given the
flawed trial designs in most of the prospective trials.
Clearly, further study on renovascular disease may lead us
to better medical management, patient selection for
intervention, and technical success in those patients that
are intervened upon. I do not believe a global position of
benign neglect of renal artery disease will be in the best
interest of patients with this morbid condition. There are
some current posits that require re-examination. The
following widely held myths need scrutiny:
Myth 1. Atherosclerosis in the renal arteries is
benign
In every arterial bed, the severe consequences of arterial
narrowing secondary to atherosclerosis are recognized. The* Tel.: þ1 216 844 1631.
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